Correlates of long-term responders.
REGRESSION
Logistic regression analyses of starting material PBMC and final DP correlates from long-term responders (patients with PFS ≥ 18 months; Recent exposure to various prior antimyeloma therapies (hematopoietic stem cell transplantation (HSCT), alkylators, anti-CD38 antibody, corticosteroids, IMiDs and proteasome inhibitors) was analyzed as a potential correlate of the PBMC features enriched in long-term responders (Fig. 